Clinical therapeutics
-
Clinical therapeutics · Mar 2002
Randomized Controlled Trial Multicenter Study Clinical TrialSafety and local tolerability of intramuscularly administered ertapenem diluted in lidocaine: a prospective, randomized, double-blind study versus intramuscular ceftriaxone.
Ertapenem is a new, structurally unique, parenteral beta-lactam antimicrobial agent that can be administered once daily. ⋯ Ertapenem 1 g (reconstituted in lidocaine) administered once daily IM was generally well tolerated. The tolerability and safety profiles of IM ertapenem therapy in this study were comparable to those of IM ceftriaxone therapy.